Page last updated: 2024-11-04

rolipram and Meconium Aspiration Syndrome

rolipram has been researched along with Meconium Aspiration Syndrome in 1 studies

Meconium Aspiration Syndrome: A condition caused by inhalation of MECONIUM into the LUNG of FETUS or NEWBORN, usually due to vigorous respiratory movements during difficult PARTURITION or respiratory system abnormalities. Meconium aspirate may block small airways leading to difficulties in PULMONARY GAS EXCHANGE and ASPIRATION PNEUMONIA.

Research Excerpts

ExcerptRelevanceReference
" This study aimed to investigate the pathophysiological effects of an intravenous PDE4 inhibitor (rolipram) and surfactant lavage (SL) in a newborn piglet model of meconium aspiration syndrome (MAS)."3.96Pathophysiological effects of intravenous phosphodiesterase type 4 inhibitor in addition to surfactant lavage in meconium-injured newborn piglet lungs. ( Chen, WY; Jeng, MJ; Lee, YS; Lin, CH; Tsao, PC, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, WY1
Lin, CH1
Lee, YS1
Tsao, PC1
Jeng, MJ1

Other Studies

1 other study available for rolipram and Meconium Aspiration Syndrome

ArticleYear
Pathophysiological effects of intravenous phosphodiesterase type 4 inhibitor in addition to surfactant lavage in meconium-injured newborn piglet lungs.
    Pediatric pulmonology, 2020, Volume: 55, Issue:9

    Topics: Administration, Intravenous; Animals; Animals, Newborn; Bronchoalveolar Lavage; Combined Modality Th

2020